Emerging SARS-CoV-2 variants expand species tropism to murines
Huiping Shuai,Jasper Fuk-Woo Chan,Terrence Tsz-Tai Yuen,Chaemin Yoon,Jing-Chu Hu,Lei Wen,Bingjie Hu,Dong Yang,Yixin Wang,Yuxin Hou,Xiner Huang,Yue Chai,Chris Chung-Sing Chan,Vincent Kwok-Man Poon,Lu Lu,Rui-Qi Zhang,Wan-Mui Chan,Jonathan Daniel Ip,Allen Wing-Ho Chu,Ye-Fan Hu,Jian-Piao Cai,Kwok-Hung Chan,Jie Zhou,Siddharth Sridhar,Bao-Zhong Zhang,Shuofeng Yuan,Anna Jinxia Zhang,Jian-Dong Huang,Kelvin Kai-Wang To,Kwok-Yung Yuen,Hin Chu
DOI: https://doi.org/10.1016/j.ebiom.2021.103643
IF: 11.205
2021-11-01
EBioMedicine
Abstract:BACKGROUND: Wildtype mice are not susceptible to SARS-CoV-2 infection. Emerging SARS-CoV-2 variants, including B.1.1.7, B.1.351, P.1, and P.3, contain mutations in spike that has been suggested to associate with an increased recognition of mouse ACE2, raising the postulation that these SARS-CoV-2 variants may have evolved to expand species tropism to wildtype mouse and potentially other murines. Our study evaluated this possibility with substantial public health importance.METHODS: We investigated the capacity of wildtype (WT) SARS-CoV-2 and SARS-CoV-2 variants in infecting mice (Mus musculus) and rats (Rattus norvegicus) under in vitro and in vivo settings. Susceptibility to infection was evaluated with RT-qPCR, plaque assays, immunohistological stainings, and neutralization assays.FINDINGS: Our results reveal that B.1.1.7 and other N501Y-carrying variants but not WT SARS-CoV-2 can infect wildtype mice. High viral genome copies and high infectious virus particle titres are recovered from the nasal turbinate and lung of B.1.1.7-inocluated mice for 4-to-7 days post infection. In agreement with these observations, robust expression of viral nucleocapsid protein and histopathological changes are detected from the nasal turbinate and lung of B.1.1.7-inocluated mice but not that of the WT SARS-CoV-2-inoculated mice. Similarly, B.1.1.7 readily infects wildtype rats with production of infectious virus particles.INTERPRETATION: Our study provides direct evidence that the SARS-CoV-2 variant, B.1.1.7, as well as other N501Y-carrying variants including B.1.351 and P.3, has gained the capability to expand species tropism to murines and public health measures including stringent murine control should be implemented to facilitate the control of the ongoing pandemic.FUNDING: A full list of funding bodies that contributed to this study can be found in the Acknowledgements section.
medicine, research & experimental